The role of cell surface HLA-B27 heavy chain homodimer interactions with NK receptors in the pathogenesis of spondyloarthritis

The role of cell surface HLA-B27 heavy chain homodimer interactions with NK receptors in the pathogenesis of spondyloarthritis

Dades bibliogràfiques
Autor principal:	Kollnberger, S
Format:	Conference item
Publicat:	2005

Ítems similars

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
per: Kollnberger, S, et al.
Publicat: (2004)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
per: Bowness, P, et al.
Publicat: (2003)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
per: Kollnberger, S, et al.
Publicat: (2007)

HLA-B-27 heavy chain homodimer formation and natural killer cell family interaction - comparison of two HLA-B-27 subtypes in vitro
per: Giles, J, et al.
Publicat: (2008)

The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
per: Kollnberger, S, et al.
Publicat: (2009)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
per: Rysnik, O, et al.
Publicat: (2012)

Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
per: Kollnberger, S, et al.
Publicat: (2002)

Identification and characterisation of cell surface HLA-B27 homodimers
per: Bird, L, et al.
Publicat: (2002)

HLA-B27 FORMS HEAVY CHAIN HOMODIMERS IN VITRO AND IN VIVO THAT BIND TO CELLULAR RECEPTORS INCLUDING LILR AND KIR FAMILY MEMBERS
per: McHugh, K, et al.
Publicat: (2010)

The pathogenesis of spondyloarthritides - HLA-B-27 homodimer expression on human monocyte/macrophage cell lines
per: McHugh, K, et al.
Publicat: (2008)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
per: Kollnberger, S, et al.
Publicat: (2012)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
per: Wong-Baeza, I, et al.
Publicat: (2011)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

The role of HLA-B27 in the pathogenesis of spondyloarthritis
per: McHugh, K
Publicat: (2011)

Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis
per: Hatano, H, et al.
Publicat: (2013)

Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
per: Bird, L, et al.
Publicat: (2003)

HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.
per: Giles, J, et al.
Publicat: (2012)

The role of NK family receptor interactions with HLA-B27 in Ankylosing Spondylitis pathogenesis
per: Giles, J
Publicat: (2011)

HLA B27 can form heavy chain homodimers in vivo and in vivo, possible role of cys 67.
per: Bowness, P, et al.
Publicat: (1998)

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
per: Payeli, S, et al.
Publicat: (2012)

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.
per: Osiris Marroquin Belaunzaran, et al.
Publicat: (2015-01-01)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
per: Kollnberger, S, et al.
Publicat: (2007)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
per: Giles, J, et al.
Publicat: (2010)

CELL SURFACE EXPRESSION OF HLA B27 HEAVY CHAINS AND SPECIFIC RECOGNITION BY IMMUNE RECEPTORS, POSSIBLE ROLE IN SPONDYLOARTHROPATHY
per: Kollnberger, S, et al.
Publicat: (2002)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
per: Rysnik, O, et al.
Publicat: (2012)

Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
per: Allen, R, et al.
Publicat: (1999)

The role of HLA-B27 in spondyloarthritis.
per: Allen, R, et al.
Publicat: (1999)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
per: Ridley, A, et al.
Publicat: (2013)

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
per: Bowness, P, et al.
Publicat: (2011)

HD6: a novel monoclonal antibody that recognises a subset of HLA-B27 molecules strongly implicated in spondyloarthritis disease pathogenesis
per: McHugh, K, et al.
Publicat: (2011)

Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis
per: Chan, A, et al.
Publicat: (2005)

HLA-B*2709, A SUBTYPE NOT ASSOCIATED WITH ANKYLOSING SPONDYLITIS, FORMS FEWER HOMODIMERS THAN HLA-B*2705
per: Giles, J, et al.
Publicat: (2010)

HD6: A NOVEL MONOCLONAL ANTIBODY THAT RECOGNISES A SUBSET OF HLA-B27 MOLECULES STRONGLY IMPLICATED IN SPONDYLOARTHRITIS DISEASE PATHOGENESIS
per: McHugh, K, et al.
Publicat: (2011)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue
per: Rysnik, O, et al.
Publicat: (2016)

THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09
per: Shaw, J, et al.
Publicat: (2013)

The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status?
per: Coates, LC, et al.
Publicat: (2020)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
per: McMichael, A, et al.
Publicat: (2002)

Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection
per: Chengappa G. Kavadichanda, et al.
Publicat: (2021-03-01)

The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
per: Cauli, A, et al.
Publicat: (2013)